This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Patrys Limited, Debiovision Inc.. Active years: 2008-2017.
Location History:
- Würzburg, DE (2008)
- Wurzburg, DE (2016 - 2017)
Company Filing History:
Years Active: 2008-2017
Title: Frank Hensel: Innovator in Antibody Development
Introduction
Frank Hensel is a notable inventor based in Wurzburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and their applications in medical treatments. With a total of 3 patents to his name, Hensel's work has the potential to impact cancer treatment and diagnostics.
Latest Patents
Hensel's latest patents include innovations related to LM-antibodies and functional fragments. One of his key inventions provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid, and other compositions. These inventions are designed to bind to the LM-1 antigen, which is crucial in the treatment of neoplasia, tumors, or cancer. One method described in his patents involves administering LM-1 antibodies to treat metastasis in subjects requiring medical intervention. Additionally, he has developed methods related to the PAT-LM1 epitopes, further expanding the potential applications of his research.
Career Highlights
Throughout his career, Frank Hensel has worked with various companies, including Patrys Limited and Debiovision Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications. Hensel's innovative approach has positioned him as a key figure in the biotechnology sector.
Collaborations
Hensel has collaborated with notable professionals in his field, including Heinz Peter Vollmers and Leodevico Luna Ilag. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Frank Hensel's contributions to the field of biotechnology, particularly in antibody development, demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of research in improving treatment options for cancer and other diseases.